Hi Spec
I think you answered your own question.
2017 was a year of base building, 2018 will be the year of consolidation as production steps up , refinancing the balance sheet, and starting the execution of the Aneth PUD development.
I would expect a slow sp increase as the milestones are hit .
IMO the market wants to see the plan they have articulated move forward, but the main stumbling block being the high debt . When it becomes apparent the the free cash being produced (especially when refinancing is achieved and if the POO stays around current levels ) is significant, we may see the shackles come off a bit.
Remember that the market may be low at around A$120 million, but the enterprise value when including the debt and preferred equity is closer to A$ 400 million, you could argue that ELK right now is fully valued .
Cheers
Dan
- Forums
- ASX - By Stock
- Ann: Half Year FY2018 Results & Guidance
Hi Spec I think you answered your own question. 2017 was a year...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ELK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online